Twist Bioscience’s cover photo
Twist Bioscience

Twist Bioscience

Biotechnology Research

South San Francisco, California 159,231 followers

Synthetic DNA for Health & Sustainability

About us

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. Twitter @TwistBioscience Facebook facebook.com/TwistBioscience YouTube youtube.com/TwistBioscience #WeMakeDNA

Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
South San Francisco, California
Type
Public Company
Founded
2013
Specialties
Synthetic Biology, DNA, Biotechnology, Drug Discovery, Gene Synthesis, Primers, NGS, Oligonucleotides, Life Sciences, Synthetic DNA, Next Gen Sequencing, CRISPR, DNA Data Storage, Variant Libraries, DNA Sequencing, Pharmaceutical, Exome Sequencing, Target Enrichmentt, CRISPR Libraries, and Core Exome

Locations

Employees at Twist Bioscience

Updates

  • 🎉 We are excited to announce our collaboration with CURIO Genomics to accelerate the adoption of NGS workflows in agricultural genomics by offering Twist’s FlexPrep™ Ultra-High Throughput (UHT) Library Preparation Kit with Curio’s bioinformatics software and data platform! “Our FlexPrep UHT Library Prep Kit eliminates many of the traditional barriers that have slowed NGS adoption in agrigenomics – making high throughput genotyping faster, easier, and more accessible than ever,” said Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “By collaborating with Curio, we can now pair our FlexPrep UHT Kit with a robust easy-to-use, cost-effective software platform to conduct high-volume data analysis across array and NGS data from any animal or plant species. From library prep to data analytics, we believe this streamlined offering will facilitate a shift from microarray to next-generation sequencing.” Find the kit here: https://lnkd.in/gFd7PSMy Learn more about the collaboration: https://lnkd.in/gWTr_aNV Twist Bioscience, #DNA #agrigenomics

    • No alternative text description for this image
  • Join Twist Bioscience for upcoming webinar! 🖥️ Advanced Targeted Sequencing: Unraveling the Complexity of Plant Genetic Diversity 🗓️ Date: April 15th, 2025 ⏰ Time: 4:00 PM CEST | 3:00 PM BST | 8:00 AM PDT Hear from Caroline Callot and william marande at INRAE-CNRGV about how targeted sequencing is revolutionizing plant genomic research. What You Will Learn: •The advantages of targeted enrichment methods in plant genome analysis. •Real-world applications in characterizing pathogen resistance and large genomic regions. •The use of Long Read sequencing combined with Twist Target Enrichment. •How CNRGV is advancing plant research. Don’t miss this opportunity to expand your knowledge in plant genomics! RSVP here: https://lnkd.in/gXFz8KJt

    • No alternative text description for this image
  • 📣 Cancer researchers, cellular biologists, genomics and exome specialists, this is for you! We’ve rounded up publications— hot off the press within the last two weeks and all open access! For your reading pleasure: Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product: https://lnkd.in/gevypMbN David Willoughby, Frontage Laboratories, Inc, Gradalis, Inc. Precise engineering of gene expression by editing plasticity: https://lnkd.in/gv5DNYq7 Gearing up Golden Braid assembly for plant synthetic genomics with RepTiles: https://lnkd.in/gS-m5Sz6 Uriel Urquiza Garcia, University of Düsseldorf Structural mechanisms for centrosomal recruitment and organization of the microtubule nucleator γ-TuRC: https://lnkd.in/gVFUVfb9 Heidelberg University Thanks to all the authors for choosing Twist products to support their work! 🧬 Twist Bioscience, #DNA, #exome, #gene

    • No alternative text description for this image
  • 🤔 What are you doing April 1st from 8 AM - 9 AM PST? Join us for an insightful webinar comparing the performance of transgenic versus hyperimmune mice on the latest innovations in single B cell technology! 🖥️ Webinar: “A Meta-Analysis of 150+ Antibody Discovery Campaigns: Transgenic Mouse Performance Against Single B Cell Technology Trends” 🗓️ Date: April 1, 2025 ⏰ Time: 8 AM - 9 AM PST | 11 AM - 12 PM EST Experts will dive into: • Key strengths and limitations of each platform • Data-driven comparisons of antibody diversity and affinity • Emerging trends and innovations in Single B cell discovery workflows Don't miss this opportunity to gain strategic insights for your next discovery program. Secure your spot today 👉 https://lnkd.in/expZ23KS Twist Bioscience, #antibodydiscovery #TwistBiopharmaSolutions #DNA

    • No alternative text description for this image
  • Happy #ScienceAppreciationDay! “On March 26, 1953, American medical scientist Dr. Jonas Salk revealed the successful development of his polio vaccine. It was a landmark achievement of science and continues to make life healthier and safer even today. The CDC estimates the polio vaccine has prevented 18 million cases of paralysis and saved 1.5 million lives worldwide since 1988.” - sciencesaves.org 🧪 What is your favorite scientific breakthrough? 🧬 We’ll go first— the discovery of the double helix which paved the way for humanity-changing advancements like the Human Genome Project, writing DNA, and gene-editing. Twist Bioscience, #DNA

    • No alternative text description for this image
  • Spring is in the air, and so is the aroma of fresh coffee! ☕️☀️ To celebrate the warmer days and the promise of new discoveries, Twist Bioscience is bringing our Coffee Bike to your campus! Join us for a complimentary cup of coffee, a chat with our team, and a moment to soak up the spring sunshine. How to redeem your FREE coffee: 1) Register here: https://lnkd.in/gMkjyBpS 2) Show us your confirmation email at the Coffee Bike! 3) Enjoy your delicious coffee! Join us at these locations: • April 1st | 10:00 AM - 1:00 PM | Frankfurt: Campus Riedberg - Fakten Biozentrum • April 2nd | 10:00 AM - 1:00 PM | Hamburg: Audimax - Hauptcampus •April 3rd | 10:00 AM - 1:00 PM | Cologne: Mensa Zülpicher Str. - Fläche 6 oder 7 We look forward to seeing you there!

    • No alternative text description for this image
  • It’s thrilling when a significant advancement is achieved in your industry… and it this one speaks DNA! 🎉 With the potential to revolutionize drug discovery, healthcare, food production, and beyond, Evo 2 marks a significant step forward in biomolecular AI. If you need your sequences made to move your powerful digital information into the physical realm, we’d be thrilled to do that for you! 🧬 Twist Bioscience

    View organization page for NVIDIA Healthcare

    41,068 followers

    A major milestone for generative genomics. 🤝 NVIDIA, Arc Institute, and Stanford University have collaborated to create Evo 2, built using NVIDIA DGX Cloud on Amazon Web Services (AWS), a powerful AI model that's accelerating biomolecular research. 🧬 This new AI foundation model, trained on nearly 9 trillion nucleotides, can predict protein function, identify novel molecules, and evaluate gene mutation effects. 🚀 The possibilities for healthcare, agriculture, and beyond are endless Read more ➡️ https://nvda.ws/3ELrqGY

    • No alternative text description for this image
  • We are excited to invite you to an important panel discussion— Advancing Synthetic Biology Competitiveness in the AI Era. Our very own Angela Bitting and James Diggans along with Caitlin Gearen Frazer, Lynda Stuart MD PhD, and Vivek Chilukuri will discuss the importance of thinking about how to shape strategies and understand the guardrails needed at the intersection of biology, technology and national security. This is a widely-attended event open to all, and we welcome your voice in the room. 📍 Capitol Visitors Center, Room SVC 209-08 🕑 March 26 | 2:00–3:00 PM ET RSVP here: https://lnkd.in/gZ4NXAFf Twist Bioscience, #AI, #DNA, #biosecurity

    • No alternative text description for this image
  • Think of your old university essays, or cringy social media posts stored in the cloud, not to mention yesterday’s slide deck or event photo— digital storage needs are outpacing current storage methods quickly. DNA offers a long term, stable, eco-friendly, & relevant solution to the data storage crunch. Especially for cold storage. What is DNA data storage without reliable DNA? “The goal is to write DNA at terrific speeds and on a vast scale.” Twist CEO, and cofounder Emily Leproust. Read more about DNA data storage in this fantastic piece by Matthew Hutson in The New Yorker: https://lnkd.in/gqUzWdRk

    • No alternative text description for this image

Similar pages

Browse jobs

Funding

Twist Bioscience 10 total rounds

Last Round

Post IPO equity

US$ 250.0M

See more info on crunchbase